Bandingkan Harga & Kinerja Mulia Industrindo Tbk (MLIA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Mulia Industrindo Tbk dan Organon Pharma Indonesia Tbk.: Mulia Industrindo Tbk diperdagangkan di Rp220 (kapitalisasi pasar 1,46 T, volume 24 jam 41,7 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Mulia Industrindo Tbk jauh lebih besar — sekitar 14× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MLIA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 1,46 T | 104,4 M |
Volume | 41,7 rb | — |
Lot | 417 | — |
Perputaran | 9,16 jt | — |
Harga Rata-rata | 219,74 | — |
Nilai Transaksi | 9,16 jt | — |
Harga Ekuilibrium Indikatif | 220 | — |
Volume Ekuilibrium Indikatif | 81 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Mulia Industrindo Tbk
PT Mulia Industrindo Tbk (the company) was established based on Deed No. 15 dated November 5, 1986 of Liliani Handajawati Tamzil S.H., notary in Jakarta, as amended by deed No. 7 dated May 6, 1987 of the same notary.. The company's articles of association have been amended several times, most recently on January 21, 1997 regarding the change of the Company's name and par value per share. The company is one of the companies of the Mulia Group. The company started its commercial operations in 1990.
Selengkapnya di halaman MLIA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
